Back to search

France· FR:69724187

ACAMPROSATE BIOGARAN 333 mg, comprimé pelliculé gastro-résistant

A acamprosate product, registered in France by BIOGARAN, on the national reimbursement list. The same ATC class is registered in 14 of our 19 countries.

Reimbursed in France (Assurance maladie)ATC N07BB03

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedACAMPROSATE BIOGARAN 333 mg, comprimé…ATCN07BB03REGISTER NO.FR:69724187PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Acamprosate is registered in 14 of 19 countries.

Countries holding a registration under ATC N07BB03 (acamprosate), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 8 of them publish a price we can compare per daily dose

Acamprosate · ATC N07BB03

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acamprosate costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $1.14 in France to $3.37 in Switzerland — a ×3.0 gap.

  • France: $1.14 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Acamprosate · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.37
  • IT Italy$2.75
  • FR France$1.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
BIOGARAN
Country
France (FR)
ATC code
N07BB03
ATC class
Acamprosate
Defined daily dose
2 g, O
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cip13
    3400927607783
    plaquette(s) thermoformée(s) PVC PVDC aluminium de 60 comprimé(s)
    EUR 10
  • cip13
    3400927607905
    plaquette(s) thermoformée(s) PVC PVDC aluminium de 180 comprimé(s)
    EUR 29.06

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for acamprosate.

Graded by severity as the source publishes them — 19 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Acamprosate · interactions on record

19 records

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Acamprosate in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acamprosate products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Campral
  • Belgium · Campral
  • Czechia · Campral
  • Germany · Campral
  • Spain · Campral
  • United Kingdom (Northern Ireland) · Acamprosate Generics [uk] Ltd, Acamprosate Strandhaven Somex Pharma
  • Ireland · Campral Ec
  • Italy · Campral
  • Luxembourg · Campral
  • Netherlands · Campral
  • Norway · Campral
  • Poland · Campral
  • Portugal · Campral
  • Sweden · Akamprosat Viatris, Campral
  • Slovakia · Acamprosat Viatris, Campral

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d98673ae-1107-4a3f-a106-f006d8ab1595
GET /v1/drugs/d98673ae-1107-4a3f-a106-f006d8ab1595?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "69724187",
  "date_amm": "2013-10-25",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé gastro-résistant(e)",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about acamprosate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.